Phoenix delivers first production accelerator

In what is being described as a business and health care milestone, the Madison-based Phoenix LLC has delivered a neutron generator system to SHINE Medical Technologies of Janesville, putting SHINE on the path to become the leading domestic producer of a medical isotope known as Molybdenum-99, or Mo-99.

This accelerator system was designed and built by Phoenix specifically for the SHINE medical isotope project, which will produce radioisotopes used in medical imaging. Mo-99 is a radioisotope that decays into the diagnostic imaging agent technetium-99m (Tc-99m), and due to the short shelf-life and quick decay due to shipping from overseas, the domestic production of MO-99 is considered an imperative. The safe and affordable production of Mo-99 is vital for the 40 million annual medical procedures the isotope is used in.

After installation and commissioning, SHINE will begin to gain operating experience, train employees, and develop maintenance procedures prior to construction of its commercial production facility. Construction of the facility is slated to begin in the spring of 2019.

SHINE CEO Greg Piefer says the delivery represents the culmination of nearly a decade of joint work between the two companies. The work has moved from proof-of-concept to proof-of-scale and now to a commercial-ready unit that is capable of producing thousands of doses of medicine per day.